# Executive Brief: [Company/Project Name]

**Date:** [YYYY-MM-DD]
**Prepared By:** [Evaluator Name]
**Source Documents:** [List application materials used]

---

## B1: PROJECT NAME AND ONE-LINE DESCRIPTION

**Project Name:** [Official name]

**One-Line Description (MAX 150 CHARACTERS):**

[Write compelling one-line: WHO benefits, WHAT problem solved, HOW (general approach)]

**Character Count:** [___/150]

---

## B2: PROBLEM STATEMENT (MAX 300 CHARACTERS)

[Solution-neutral statement of measurable problem. Who is affected? What is current impact? Quantify when possible.]

**Character Count:** [___/300]

### Evidence Tracking

- **Validated with:** [# interviews / studies cited / data sources] or "ASSUMED"
- **Source:** [Stakeholder interviews / Published research / Industry reports / None]
- **Validation Quality:** [Strong / Moderate / Weak / None]

---

## B3: PROPOSED SOLUTION (MAX 300 CHARACTERS)

[Describe approach/method, highlight key innovation, connect to problem, avoid excessive jargon]

**Character Count:** [___/300]

### Evidence Tracking

- **Technical validation:** [Prototype tested / Proof-of-concept / Concept only]
- **User testing:** [# users tested with / pilots conducted / none]
- **Performance metrics:** [Key results if available]

---

## B4: TARGET MARKET AND USERS (MAX 300 CHARACTERS)

[Who are users? Who are buyers (if different)? Market size? Initial target segment?]

**Character Count:** [___/300]

### User/Buyer Distinction

- **Users:** [Description and size]
- **Buyers:** [Description and size, or "Same as users"]
- **Initial Target:** [Specific beachhead segment]

### Market Sizing

- **TAM (Total Addressable Market):** $[___] or [___] users
- **SAM (Serviceable Addressable Market):** $[___] or [___] users
- **Initial Target Market:** $[___] or [___] users

### Evidence Tracking

- **Market sizing method:** [Bottom-up / Top-down / Comparable markets / Assumed]
- **User interviews conducted:** [#] or "None"
- **Buyer validation:** [# discussions / LOIs / None]

---

## B5: BUSINESS MODEL AND REVENUE (MAX 300 CHARACTERS)

[How does money flow? Pricing strategy? Unit economics? Pre-revenue or current status?]

**Character Count:** [___/300]

### Revenue Details

- **Revenue Model:** [How money is made]
- **Pricing:** [Strategy, tiers if applicable]
- **LTV (Lifetime Value):** $[___] or "TBD"
- **CAC (Customer Acquisition Cost):** $[___] or "TBD"
- **LTV:CAC Ratio:** [___:1] or "TBD"
- **Gross Margin:** [___]% or "TBD"
- **Current Status:** [MRR: $___] or "Pre-revenue"

### Evidence Tracking

- **Pricing tested with:** [# customers / prospects / "Not tested"]
- **Revenue status:** [Paying customers: # / MRR: $X / "Pre-revenue"]
- **Economics validated:** [Yes with data / Projected / Assumed]

---

## B6: TRACTION AND VALIDATION (MAX 300 CHARACTERS)

[Quantify all evidence: customer validation, technical milestones, partnerships, revenue. Use specific numbers.]

**Character Count:** [___/300]

### Detailed Traction Metrics

**Customer Discovery:**
- Interviews conducted: [#]
- Key insights: [Brief summary]

**User Testing:**
- Pilot users: [#]
- Duration: [Timeframe]
- Key results: [Brief summary]

**Paying Customers:**
- Count: [#]
- MRR/ARR: $[___]
- Retention: [___]% or "TBD"

**Product Status:**
- Stage: [Concept / Prototype / MVP / Beta / Production]
- Launch date: [If applicable]
- Key metrics: [Performance data]

**Partnerships:**
- Type: [MOU / LOI / Contract]
- Partner names: [List]
- Status: [Active / Pending / Discussion]

**Funding:**
- Amount raised: $[___]
- Stage: [Pre-seed / Seed / Series A / etc.]
- Investors: [Names if applicable]

### Evidence Quality

**Red Flags:**
- [ ] Zero customer validation (no interviews)
- [ ] No working prototype or MVP
- [ ] All claims lack supporting numbers
- [ ] "In discussions" without documentation

---

## B7: TEAM AND RESOURCES (MAX 200 CHARACTERS)

[Founders with relevant experience, full-time vs part-time, critical gaps, key advisors, runway]

**Character Count:** [___/200]

### Team Details

**Founders:**

**Founder 1:**
- Name: [Full name]
- Role: [Title]
- Relevant Experience: [1-2 lines]
- Commitment: [Full-time / Part-time / Timeline to full-time]

**Founder 2:**
- Name: [Full name]
- Role: [Title]
- Relevant Experience: [1-2 lines]
- Commitment: [Full-time / Part-time / Timeline to full-time]

[Add additional founders as needed]

**Team Size:** [# FTE equivalent]

**Critical Gaps Identified:**
1. [Missing role or capability]
2. [Missing role or capability]
3. [Missing role or capability]

**Key Advisors:**
- [Name, expertise, engagement level] or "None"

**Resources:**
- Runway: [# months]
- Funding status: [Current cash, burn rate]

### Evidence Tracking

- **Team commitment:** [All full-time / Mixed / All part-time]
- **Domain expertise:** [Years in problem space]
- **Startup experience:** [Previous ventures, exits]
- **Completeness:** [All roles filled / Key gaps]

---

## MATURITY STAGE CLASSIFICATION

**Selected Stage:** [Choose one]
- [ ] Idea
- [ ] Prototype
- [ ] Pilot
- [ ] Early Commercialization
- [ ] Growth

### Maturity Stage Details

**CURRENT STAGE:** [Name]

**TRL (Technology Readiness Level):** [1-9]

**Justification (100 words max):**

[Explain stage selection citing specific evidence from B1-B7 above. Reference customer validation numbers, product status, team commitment, revenue if any.]

---

## SUPPLEMENTARY NOTES

### Market Context (MAX 250 CHARACTERS)

[Market dynamics, competitive landscape, timing factors, regulatory environment]

**Character Count:** [___/250]

---

### Strategic National/Regional Importance (MAX 250 CHARACTERS)

[Alignment with priorities, economic impact, social impact, SDG contribution]

**Character Count:** [___/250]

---

### Technology Platform Potential (MAX 250 CHARACTERS)

[Multiple use cases, scalability beyond initial market, platform vs point solution, IP/technical moat]

**Character Count:** [___/250]

---

### Key Dependencies and Risks (MAX 250 CHARACTERS)

[Critical dependencies, technical risks and mitigation, market risks, resource constraints]

**Character Count:** [___/250]

---

### Evidence Quality Assessment (MAX 250 CHARACTERS)

[Overall validation strength, major evidence gaps, data quality, recommendations for additional validation]

**Character Count:** [___/250]

---

## QUALITY CHECKLIST

**Character Limits:**
- [ ] B1 one-line description ≤ 150 characters
- [ ] B2 problem statement ≤ 300 characters
- [ ] B3 solution ≤ 300 characters
- [ ] B4 market/users ≤ 300 characters
- [ ] B5 business model ≤ 300 characters
- [ ] B6 traction ≤ 300 characters
- [ ] B7 team ≤ 200 characters
- [ ] Each supplementary note ≤ 250 characters

**Content Quality:**
- [ ] Problem statement (B2) is solution-neutral (no technology/product mentions)
- [ ] Solution (B3) clearly addresses problem in B2
- [ ] Users and buyers (B4) are clearly distinguished or noted as same
- [ ] Business model (B5) is specific with numbers
- [ ] Traction (B6) is fully quantified (no vague claims)
- [ ] Team (B7) shows relevant capability and gaps identified

**Evidence Documentation:**
- [ ] Every major claim has evidence tracking
- [ ] Sources documented or marked "ASSUMED"
- [ ] Numbers provided (# interviews, # pilots, etc.)
- [ ] Red flags noted explicitly if present

**Maturity Stage:**
- [ ] Stage classification matches evidence
- [ ] TRL rating is defensible
- [ ] Justification cites specific evidence

**Supplementary Notes:**
- [ ] All subsections respect 250-char limits
- [ ] Important context captured
- [ ] Risks and dependencies noted
- [ ] Evidence quality honestly assessed

---

## RED FLAGS IDENTIFIED

Check any that apply:

- [ ] Zero customer validation (no interviews conducted)
- [ ] No working technology (concept only, no prototype)
- [ ] Part-time team with no timeline to full-time
- [ ] Missing critical evidence for major claims
- [ ] Business model unclear or untested
- [ ] Market sizing unsupported or unrealistic
- [ ] No clear differentiation from competitors
- [ ] Resource constraints (funding, team, partnerships)

**Red Flag Details:**

[If any red flags checked, provide specific details and implications]

---

## FILE OUTPUTS

**Save as:**
- Markdown: `[CompanyName]_[YYYY-MM-DD]_00_ExecutiveBrief.md`
- DOCX: `[CompanyName]_[YYYY-MM-DD]_00_ExecutiveBrief.docx`

**Example:**
- `HealthTech_2025-01-15_00_ExecutiveBrief.md`
- `HealthTech_2025-01-15_00_ExecutiveBrief.docx`

---

## NEXT STEPS

After completing Executive Brief:

1. **Verify all character limits met**
2. **Check evidence tracking complete**
3. **Identify major gaps requiring follow-up**
4. **Save both MD and DOCX versions**
5. **Proceed to:**
   - Step 1 (Application Forms) if needed, OR
   - Step 2 (40-Question Diagnostic) directly

**Estimated Time:** 20-30 minutes

---

**Template Version:** 1.0 - Step 0 Executive Brief
**Last Updated:** 2025-01-15
**Compatible with:** VIANEO 8-Step Evaluation System
